Cite
HARVARD Citation
Pietroboni, A. et al. (2017). CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Multiple sclerosis. pp. 1085-1091. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pietroboni, A. et al. (2017). CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Multiple sclerosis. pp. 1085-1091. [Online].